Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial

PaperCitations, authors & open-access status

Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 121 citations, 2021 year and gold oa status.

121
Citations
2021
Year
gold
OA Status

Related on ScholarIQ

Tiantian Li
Author
EBioMedicine
Journal
Mesenchymal stem cell research
Topic
Mesenchymal stem cell research
Topic
COVID-19 Clinical Research Studies
Topic
Dermatological and COVID-19 studies
Topic
470M+ articles · free account